本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

0.8191
+0.00670.82%
盘后0.7811-0.0380-4.64%18:37 EDT
成交量:2.29万
成交额:1.87万
市值:2,671.47万
市盈率:-1.51
高:0.8340
开:0.8201
低:0.8001
收:0.8124
52周最高:3.85
52周最低:0.5714
股本:3,261.47万
流通股本:562.08万
量比:0.03
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-0.5428
每股收益(LYR):-1.6570
净资产收益率:-112.02%
总资产收益率:-28.56%
市净率:1.04
市盈率(LYR):-0.49

数据加载中...

2020/03/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC问询函

[Cover]Correspondence
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

招股说明书

Registration statement for certain foreign private issuers
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

SEC问询函

[Cover]Correspondence
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers